Faraday Future executives receive subpoenas from SEC, says it is ‘cooperating fully’
Baird Downgrades Verra Mobility to Neutral
Baird analyst David Koning downgrades Verra Mobility (NASDAQ:VRRM) from Outperform to Neutral.
Related Posts
Two Organizations To Support Wave Life Sciences’ FTD, ALS Program
The Alzheimer's Drug Discovery Foundation (ADDF) and The Association for Frontotemporal Degeneration (AFTD) will support Wave Life Sciences Ltd's (NASDAQ: WVE) amyotrophic lateral sclerosis (ALS) and frontotemporal degeneration (FTD) program.
Catabasis Renames As Astria Therapeutics With New Disease Focus
Once-struggling, Catabasis Pharmaceuticals Inc (NASDAQ:CATB) is looking to hit the reset button with a new name and focus. Catabasis has been…
Oppenheimer Maintains Outperform on Sweetgreen, Lowers Price Target to $37
Oppenheimer analyst Brian Bittner maintains Sweetgreen (NYSE:SG) with a Outperform and lowers the price target from $41 to $37.